Filtros de búsqueda

Lista de obras de Diana Spiegelberg

A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio

artículo científico publicado en 2012

A real-time in vitro assay as a potential predictor of in vivo tumor imaging properties.

artículo científico publicado en 2015

CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches

artículo científico publicado en 2017

Characterization of CD44 variant expression in head and neck squamous cell carcinomas

artículo científico publicado en 2014

Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6.

artículo científico publicado en 2013

Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.

artículo científico publicado en 2014

Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.

artículo científico publicado en 2015

HSP90 inhibition in angiosarcoma

artículo científico publicado en 2017

Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody molecules.

artículo científico publicado en 2011

In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.

scientific article published on 06 March 2014

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy

artículo científico publicado en 2018

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

scientific article published on 03 April 2020

The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells

artículo científico publicado en 2019

The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors

artículo científico publicado en 2018

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells

artículo científico publicado en 2019

The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

artículo científico publicado en 2011

The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells

artículo científico publicado en 2015

The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda